Download PDF
CC BY 4.0 · Aorta (Stamford) 2014; 02(04): 147-151
DOI: 10.12945/j.aorta.2014.13-048
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Development of Mega-Aorta Following Incompletely Treated Giant Cell Arteritis

Darwin Eton
1   Section of Vascular Surgery and Endovascular Therapy, Department of Surgery, University of Chicago Medicine, Chicago, Illinois
,
Atman P. Shah
2   Section of Cardiology, Department of Medicine, University of Chicago Medicine, Chicago, Illinois
,
Aurelie Merlo
3   Cardiovascular Clinical Research Unit, Barnabas Heart Hospitals, Newark, New Jersey
,
Karin Dill
4   Department of Radiology, University of Chicago Medicine, Chicago, Illinois
,
Mark J. Russo
3   Cardiovascular Clinical Research Unit, Barnabas Heart Hospitals, Newark, New Jersey
5   Newark Beth Israel Medical Center, Barnabas Heart Hospitals, Newark, New Jersey
› Author Affiliations
Further Information

Publication History

01 September 2013

16 July 2014

Publication Date:
24 September 2018 (online)

Also available at
   Permissions and Reprints

Abstract

An 82-year-old male presented with a 9.3 cm ascending aorta and arch aneurysm with additional aneurysms of the innominate, right subclavian, and left common carotid arteries. The patient had a history of temporal arteritis that was only briefly treated in 1989 and a 6 cm ascending aortic aneurysm that was repaired in 1993. Our operative strategy was to construct a temporary parallel cerebrovascular circuit for cerebral protection during the redo-sternotomy and aortic arch reconstruction, with the added benefit of permanently excluding the branch arch vessel aneurysms. Pathological analysis of the aortic specimen at the first operation may have identified giant cell arteritis, prompting medical therapy against further disease progression.

Key Words

Aortic aneurysm - Inflammation - Subclavian artery - Carotid artery
 

  • References

  • 1 Goodwin JS. Progress in gerontology: polymyalgia rheumatica and temporal arteritis. J Am Geriatr Soc 1992; 40: 515-525
    CrossrefPubMedGoogle Scholar
  • 2 Cid MC, García-Martínez A, Lozano E, Espígol-Frigolé G, Hernández-Rodríguez J. Five clinical conundrums in the management of giant cell arteritis. Rheum Dis Clin North Am 2007; 33: 819-834 , vii. 10.1016/j.rdc.2007.08.001
    CrossrefPubMedGoogle Scholar
  • 3 Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123: 192-194 . 10.7326/0003-4819-123-3-199508010-00006
    PubMedGoogle Scholar
  • 4 Morgan AW, Robinson JI, Barrett JH, Martin J, Walker A, Babbage SJ, Ollier WE, Gonzalez-Gay MA, Isaacs JD. Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res Ther 2006; 8: R109 . 10.1186/ar1996
    CrossrefPubMedGoogle Scholar